Lantern Pharma Inc (LTRN)
6.13
-0.01
(-0.16%)
USD |
NASDAQ |
May 17, 16:00
6.00
-0.13
(-2.12%)
After-Hours: 20:00
Lantern Pharma Total Assets (Quarterly): 39.73M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 39.73M |
| December 31, 2023 | 43.65M |
| September 30, 2023 | 47.77M |
| June 30, 2023 | 51.43M |
| March 31, 2023 | 55.51M |
| December 31, 2022 | 58.84M |
| September 30, 2022 | 62.16M |
| June 30, 2022 | 66.38M |
| March 31, 2022 | 68.40M |
| Date | Value |
|---|---|
| December 31, 2021 | 73.95M |
| September 30, 2021 | 77.61M |
| June 30, 2021 | 82.43M |
| March 31, 2021 | 82.50M |
| December 31, 2020 | 20.36M |
| September 30, 2020 | 22.49M |
| June 30, 2020 | 25.61M |
| March 31, 2020 | 1.038M |
| December 31, 2019 | 1.433M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.038M
Minimum
Mar 2020
82.50M
Maximum
Mar 2021
48.96M
Average
53.47M
Median
Total Assets (Quarterly) Benchmarks
| Eyenovia Inc | 26.18M |
| Cassava Sciences Inc | 155.72M |
| Alpine Immune Sciences Inc | 373.65M |
| Clearside Biomedical Inc | 40.14M |
| Poseida Therapeutics Inc | 262.58M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.969M |
| Shareholders Equity (Quarterly) | 35.77M |